247 related articles for article (PubMed ID: 22664150)
21. Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale.
Hundsberger T; Schoser B; Leupold D; Rösler KM; Putora PM
J Neurol; 2019 Aug; 266(8):2010-2017. PubMed ID: 31104135
[TBL] [Abstract][Full Text] [Related]
22. Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy.
Jones HN; Hobson-Webb LD; Kuchibhatla M; Crisp KD; Whyte-Rayson A; Batten MT; Zwelling PJ; Kishnani PS
Mol Genet Metab; 2021 Jul; 133(3):261-268. PubMed ID: 34053870
[TBL] [Abstract][Full Text] [Related]
23. Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment.
Montagnese F; Barca E; Musumeci O; Mondello S; Migliorato A; Ciranni A; Rodolico C; De Filippi P; Danesino C; Toscano A
J Neurol; 2015; 262(4):968-78. PubMed ID: 25673129
[TBL] [Abstract][Full Text] [Related]
24. Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies.
Pichiecchio A; Sacco S; De Filippi P; Caverzasi E; Ravaglia S; Bastianello S; Danesino C
J Neurol; 2017 Oct; 264(10):2110-2118. PubMed ID: 28856460
[TBL] [Abstract][Full Text] [Related]
25. Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease.
Moriggi M; Capitanio D; Torretta E; Barbacini P; Bragato C; Sartori P; Moggio M; Maggi L; Mora M; Gelfi C
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799647
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing.
Lévesque S; Auray-Blais C; Gravel E; Boutin M; Dempsey-Nunez L; Jacques PE; Chenier S; Larue S; Rioux MF; Al-Hertani W; Nadeau A; Mathieu J; Maranda B; Désilets V; Waters PJ; Keutzer J; Austin S; Kishnani P
Orphanet J Rare Dis; 2016 Jan; 11():8. PubMed ID: 26809617
[TBL] [Abstract][Full Text] [Related]
27. Central nervous system involvement in late-onset Pompe disease: clues from neuroimaging and neuropsychological analysis.
Musumeci O; Marino S; Granata F; Morabito R; Bonanno L; Brizzi T; Lo Buono V; Corallo F; Longo M; Toscano A
Eur J Neurol; 2019 Mar; 26(3):442-e35. PubMed ID: 30312517
[TBL] [Abstract][Full Text] [Related]
28. Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease.
Horvath JJ; Austin SL; Case LE; Greene KB; Jones HN; Soher BJ; Kishnani PS; Bashir MR
Muscle Nerve; 2015 May; 51(5):722-30. PubMed ID: 25155446
[TBL] [Abstract][Full Text] [Related]
29. Potential patient screening for late-onset Pompe disease in suspected sleep apnea: a rationale and study design for a Prospective Multicenter Observational Cohort Study in Japan (PSSAP-J Study).
Yamauchi M; Nakayama H; Shiota S; Ohshima Y; Terada J; Nishijima T; Kosuga M; Kitamura T; Tachibana N; Oguri T; Shirahama R; Aoki Y; Ishigaki K; Sugie K; Yagi T; Muraki H; Fujita Y; Takatani T; Muro S
Sleep Breath; 2021 Jun; 25(2):695-704. PubMed ID: 32808237
[TBL] [Abstract][Full Text] [Related]
30. Late form of Pompe disease with glycogen storage in peripheral nerves axons.
Fidziańska A; Ługowska A; Tylki-Szymańska A
J Neurol Sci; 2011 Feb; 301(1-2):59-62. PubMed ID: 21109266
[TBL] [Abstract][Full Text] [Related]
31. Bright tongue sign in patients with late-onset Pompe disease.
Karam C; Dimitrova D; Yutan E; Chahin N
J Neurol; 2019 Oct; 266(10):2518-2523. PubMed ID: 31256280
[TBL] [Abstract][Full Text] [Related]
32. Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study.
Figueroa-Bonaparte S; Llauger J; Segovia S; Belmonte I; Pedrosa I; Montiel E; Montesinos P; Sánchez-González J; Alonso-Jiménez A; Gallardo E; Illa I; ; Díaz-Manera J
Sci Rep; 2018 Jul; 8(1):10898. PubMed ID: 30022036
[TBL] [Abstract][Full Text] [Related]
33. Quantification of muscle pathology in infantile Pompe disease.
Schänzer A; Kaiser AK; Mühlfeld C; Kulessa M; Paulus W; von Pein H; Rohrbach M; Viergutz L; Mengel E; Marquardt T; Neubauer B; Acker T; Hahn A
Neuromuscul Disord; 2017 Feb; 27(2):141-152. PubMed ID: 27927596
[TBL] [Abstract][Full Text] [Related]
34. A Case of Adult-onset Pompe Disease with Cerebral Stroke and Left Ventricular Hypertrophy.
Hossain MA; Miyajima T; Akiyama K; Eto Y
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3046-3052. PubMed ID: 30093193
[TBL] [Abstract][Full Text] [Related]
35. Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): Effects of training and detraining.
Jones HN; Crisp KD; Robey RR; Case LE; Kravitz RM; Kishnani PS
Mol Genet Metab; 2016 Feb; 117(2):120-8. PubMed ID: 26381077
[TBL] [Abstract][Full Text] [Related]
36. High-resolution light microscopy (HRLM) and digital analysis of Pompe disease pathology.
Lynch CM; Johnson J; Vaccaro C; Thurberg BL
J Histochem Cytochem; 2005 Jan; 53(1):63-73. PubMed ID: 15637339
[TBL] [Abstract][Full Text] [Related]
37. Restrictive Arteriopathy in Late-Onset Pompe Disease: Case Report and Review of the Literature.
Malhotra K; Carrington DC; Liebeskind DS
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):e172-e175. PubMed ID: 28647415
[TBL] [Abstract][Full Text] [Related]
38. Screening for late-onset Pompe disease in western Denmark.
Hansen JS; Pedersen EG; Gaist D; Bach FW; Vilholm OJ; Sandal B; Weitemeyer L; Nielsen K; Schlesinger FE; Preisler N; Vissing J; Andersen H
Acta Neurol Scand; 2018 Jan; 137(1):85-90. PubMed ID: 28832912
[TBL] [Abstract][Full Text] [Related]
39. Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessment.
Gaeta M; Musumeci O; Mondello S; Ruggeri P; Montagnese F; Cucinotta M; Vinci S; Milardi D; Toscano A
Neuromuscul Disord; 2015 Nov; 25(11):852-8. PubMed ID: 26410244
[TBL] [Abstract][Full Text] [Related]
40. Qualitative interviews to improve patient-reported outcome measures in late-onset Pompe disease: the patient perspective.
Hamed A; An Haack K; Gwaltney C; Baranowski E; Stewart A; Krupnick R; Tyler M; Sparks S; Paty J
Orphanet J Rare Dis; 2021 Oct; 16(1):428. PubMed ID: 34641935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
